Prostaglandin EP2 receptor: Novel therapeutic target for human cancers (Review)
Authors:
Open Access
- 26 June 2018
- journal article
- review article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 42 (3) , 1203-1214
Abstract
Prostaglandin E2 (PGE2) receptor 2 subtype (EP2), which is a metabolite of arachidonic acid that binds with and regulates cellular responses to PGE2, is associated with numerous physiological and pathological events in a wide range of tissues. As a stimulatory G protein‑coupled receptor, PGE2‑induced EP2 activation can activate adenylate cyclase, leading to increased cytoplasmic cAMP levels and activation of protein kinase A. The EP2 receptor can also activate the glycogen synthase kinase 3β and β‑catenin pathways. The present study aimed to review the roles of the EP2 receptor in tumor development, including immunity, chronic inflammation, angiogenesis, metastasis and multidrug resistance. Furthermore, the involvement of the EP2 receptor signaling pathway in cancer was discussed. Understanding the role and mechanisms of action of the EP2 receptor, and its importance in targeted therapy, may help identify novel methods to improve management of numerous types of cancer.Keywords
This publication has 109 references indexed in Scilit:
- Regulation of Rat Intrapulmonary Arterial Tone by Arachidonic Acid and Prostaglandin E2 during HypoxiaPLOS ONE, 2013
- The role of the EP receptors for prostaglandin E2 in skin and skin cancerCancer and Metastasis Reviews, 2011
- In vitroandin vivocharacterization of PF‐04418948, a novel, potent and selective prostaglandin EP2receptor antagonistBritish Journal of Pharmacology, 2011
- Tumor-secreted PGE2 Inhibits CCL5 Production in Activated Macrophages through cAMP/PKA Signaling PathwayJournal of Biological Chemistry, 2011
- Receptor desensitization and blockade of the suppressive effects of prostaglandin E2 and adenosine on the cytotoxic activity of human melanoma-infiltrating T lymphocytesCancer Immunology, Immunotherapy, 2010
- PTGER2 Overexpression in Colorectal Cancer Is Associated with Microsatellite Instability, Independent of CpG Island Methylator PhenotypeCancer Epidemiology, Biomarkers & Prevention, 2010
- PGE2 receptor EP2 mediates the antagonistic effect of COX‐2 on TGF‐β signaling during mammary tumorigenesisThe FASEB Journal, 2009
- The prostaglandin receptor EP2 activates multiple signaling pathways and -arrestin1 complex formation during mouse skin papilloma developmentCarcinogenesis, 2009
- Chemotactic action of prostaglandin E2on mouse mast cells acting via the PGE2receptor 3Proceedings of the National Academy of Sciences, 2007
- Evolution of Key Cell Signaling and Adhesion Protein Families Predates Animal OriginsScience, 2003